M, N., T, Y., T, K., & S, N. (2017). New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer. Dove Medical Press.
Chicago Style (17th ed.) CitationM, Niki, Yokoi T, Kurata T, and Nomura S. New Prognostic Biomarkers and Therapeutic Effect of Bevacizumab for Patients with Non-small-cell Lung Cancer. Dove Medical Press, 2017.
MLA (8th ed.) CitationM, Niki, et al. New Prognostic Biomarkers and Therapeutic Effect of Bevacizumab for Patients with Non-small-cell Lung Cancer. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.